Bitcoin halving
What does that mean?
$2.78T
Total marketcap
$106.31B
Total volume
BTC 49.59%     ETH 15.32%
Dominance

Hangzhou Tigermed Consulting Co., Ltd 300347.SZ Stock

53.15 CNY {{ price }} 1.722491% {{change_pct}}%
COUNTRY
China
Exchange
Shenzhen
Market Cap
42.16B CNY
LOW - HIGH [24H]
51.4 - 54.48 CNY
VOLUME [24H]
23.46M CNY
{{ volume }}
P/E Ratio
19.68
Earnings per share
2.7 CNY

Hangzhou Tigermed Consulting Co., Ltd Price Chart

Hangzhou Tigermed Consulting Co., Ltd 300347.SZ Financial and Trading Overview

Hangzhou Tigermed Consulting Co., Ltd stock price 53.15 CNY
Previous Close 74.13 CNY
Open 74.15 CNY
Bid 73.16 CNY x 0
Ask 73.17 CNY x 0
Day's Range 72.33 - 74.85 CNY
52 Week Range 69.89 - 134.8 CNY
Volume 9.43M CNY
Avg. Volume 6.69M CNY
Market Cap 60.73B CNY
Beta (5Y Monthly) 0.831164
PE Ratio (TTM) 30.86498
EPS (TTM) 2.7 CNY
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date May 31, 2022
1y Target Est 132.47 CNY

300347.SZ Valuation Measures

Enterprise Value 60.13B CNY
Trailing P/E 30.86498
Forward P/E 21.141619
PEG Ratio (5 yr expected) 1.08
Price/Sales (ttm) 8.586627
Price/Book (mrq) 3.1459658
Enterprise Value/Revenue 8.502
Enterprise Value/EBITDA 31.639

Trading Information

Hangzhou Tigermed Consulting Co., Ltd Stock Price History

Beta (5Y Monthly) 0.831164
52-Week Change -23.93%
S&P500 52-Week Change 20.43%
52 Week High 134.8 CNY
52 Week Low 69.89 CNY
50-Day Moving Average 89.06 CNY
200-Day Moving Average 98.1 CNY

300347.SZ Share Statistics

Avg. Volume (3 month) 6.69M CNY
Avg. Daily Volume (10-Days) 8.96M CNY
Shares Outstanding 749.29M
Float 626.95M
Short Ratio N/A
% Held by Insiders 36.00%
% Held by Institutions 34.69%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0.55
Trailing Annual Dividend Yield 0.74%
5 Year Average Dividend Yield 36.00%
Payout Ratio 0.2101
Last Split Factor 1.5:1

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 29.08%
Operating Margin (ttm) 24.47%
Gross Margin 39.84%
EBITDA Margin 26.87%

Management Effectiveness

Return on Assets (ttm) 4.08%
Return on Equity (ttm) 10.18%

Income Statement

Revenue (ttm) 7.07B CNY
Revenue Per Share (ttm) 8.18 CNY
Quarterly Revenue Growth (yoy) -0.70%
Gross Profit (ttm) 2.81B CNY
EBITDA 1.9B CNY
Net Income Avi to Common (ttm) 2.06B CNY
Diluted EPS (ttm) 2.37
Quarterly Earnings Growth (yoy) 9.70%

Balance Sheet

Total Cash (mrq) 7.65B CNY
Total Cash Per Share (mrq) 8.83 CNY
Total Debt (mrq) 2.83B CNY
Total Debt/Equity (mrq) 12.14 CNY
Current Ratio (mrq) 2.954
Book Value Per Share (mrq) 23.252

Cash Flow Statement

Operating Cash Flow (ttm) 1.08B CNY
Levered Free Cash Flow (ttm) -398932448 CNY

Profile of Hangzhou Tigermed Consulting Co., Ltd

Country China
State N/A
City Hangzhou
Address F18, Building A – Shengda Science Park
ZIP 310051
Phone 86 57 1288 87227
Website https://www.tigermed.net
Industry Diagnostics & Research
Sector(s) Healthcare
Full Time Employees 9233

Hangzhou Tigermed Consulting Co., Ltd. provides contract research organization services in the People's Republic of China and internationally. It operates in Clinical Trial Solutions, and Clinical-related and Laboratory Services segments. The company offers regulatory submission and approval, medical translation, and good manufacturing practice (GMP) consulting services; and clinical services in the areas of medical science, early clinical and late phase development, medical monitoring, project management, patient recruitment, and quality management system. It also provides biometrics services comprising data management, biostatistics, and statistical programming; and integrated technology services, such as site management, pharmacovigilance, third party audit and training, medical imaging, clinical trial system solution, central laboratory, pre-clinical, and research hospital. Further, the company offers medical device/ in vitro diagnostics (IVD) services comprising medical device testing, regulatory submission, clinical evaluation and trials, GMP certificate, EU MDR and IVDR preparation, and value-added services; and post-marketing study, real world evidence, and vaccine clinical trial services. Hangzhou Tigermed Consulting Co., Ltd. was incorporated in 2004 and is headquartered in Hangzhou, the People's Republic of China.

Q&A For Hangzhou Tigermed Consulting Co., Ltd Stock

What is a current 300347.SZ stock price?

Hangzhou Tigermed Consulting Co., Ltd 300347.SZ stock price today per share is 53.15 CNY.

How to purchase Hangzhou Tigermed Consulting Co., Ltd stock?

You can buy 300347.SZ shares on the Shenzhen exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Hangzhou Tigermed Consulting Co., Ltd?

The stock symbol or ticker of Hangzhou Tigermed Consulting Co., Ltd is 300347.SZ.

Which industry does the Hangzhou Tigermed Consulting Co., Ltd company belong to?

The Hangzhou Tigermed Consulting Co., Ltd industry is Diagnostics & Research.

How many shares does Hangzhou Tigermed Consulting Co., Ltd have in circulation?

The max supply of Hangzhou Tigermed Consulting Co., Ltd shares is 793.25M.

What is Hangzhou Tigermed Consulting Co., Ltd Price to Earnings Ratio (PE Ratio)?

Hangzhou Tigermed Consulting Co., Ltd PE Ratio is 19.68518400 now.

What was Hangzhou Tigermed Consulting Co., Ltd earnings per share over the trailing 12 months (TTM)?

Hangzhou Tigermed Consulting Co., Ltd EPS is 2.7 CNY over the trailing 12 months.

Which sector does the Hangzhou Tigermed Consulting Co., Ltd company belong to?

The Hangzhou Tigermed Consulting Co., Ltd sector is Healthcare.